IRS-1: auditing the effectiveness of mTOR inhibitors

Cancer Cell
John B EastonPeter J Houghton

Abstract

Rapamycin analogs that inhibit mTOR signaling have antitumor activity against certain lymphomas, but treatment of solid tumors has been less encouraging despite inhibition of mTOR function. Two recent papers give insight into the potential use of mTOR inhibitors. O'Reilly et al. provide evidence that poor tumor response to rapamycins is the result of relieving mTOR-mediated feedback inhibition of insulin receptor substrate 1, and activation of Akt-mediated survival. In the second paper, Kaper et al. address the impact of pathway activation on hypoxia-mediated downregulation of mTOR signaling, raising the possibility that rapalogs could selectively inhibit hypoxic cells.

References

Aug 23, 1996·Cell·E J Brown, S L Schreiber
Aug 13, 2002·Nature Cell Biology·Ken InokiKun-Liang Guan
Aug 13, 2002·Nature Cell Biology·Christopher J PotterTian Xu
May 4, 2004·Nature Reviews. Cancer·Mary-Ann Bjornsti, Peter J Houghton
Sep 20, 2005·Cancer Cell·Nissim Hay
Nov 17, 2005·Oncogene·David R Plas, Craig B Thompson
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen

❮ Previous
Next ❯

Citations

Sep 21, 2010·Cancer Chemotherapy and Pharmacology·Christina Trojel-HansenSøren Jensby Nielsen
Feb 6, 2010·Breast Cancer Research and Treatment·Mahvash ZakikhaniMichael N Pollak
Dec 14, 2007·Cell Research·Yadi Wu, Binhua P Zhou
Aug 3, 2006·Nature Reviews. Drug Discovery·Sandrine FaivreEric Raymond
Apr 3, 2009·Nature Reviews. Molecular Cell Biology·Xiaoju Max Ma, John Blenis
Oct 29, 2008·Oncogene·T F Franke
Oct 22, 2009·The Journal of Biological Chemistry·Guido T BommerEric R Fearon
Jan 27, 2011·The Journal of Biological Chemistry·Antonella CaccamoSalvatore Oddo
Mar 20, 2010·Lymphatic Research and Biology·Arnold S Kristof
Jan 5, 2011·Sarcoma·Hemant K Bid, Peter J Houghton
Oct 17, 2008·Cancer Research·Risa ChaisuparatSilvia Montaner
Feb 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter J Houghton
Jun 21, 2008·Molecular Cancer Therapeutics·Jorge A Garcia, David Danielpour
Nov 22, 2011·PLoS Computational Biology·Joshua LequieuJeffrey D Varner
Sep 25, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Angelica Fasolo, Cristiana Sessa
Jun 26, 2007·Current Oncology Reports·Monica M Mita, Anthony W Tolcher
Aug 22, 2009·Expert Opinion on Therapeutic Targets·Xuerong Wang, Shi-Yong Sun
Feb 6, 2009·Expert Review of Anticancer Therapy·Gerhard Treiber
Jun 1, 2011·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Chen SunXiangdong Wang
Mar 3, 2009·Critical Reviews in Oncology/hematology·Gabriele CapursoGianfranco Delle Fave
Jul 18, 2006·Biochimica Et Biophysica Acta·Raushan T Kurmasheva, Peter J Houghton
Mar 31, 2015·Cancer Treatment Reviews·Laura PizzutiMaddalena Barba
Oct 4, 2007·PloS One·Natalia L Komarova, Dominik Wodarz
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alejandro Vazquez-MartinJavier A Menendez
Sep 6, 2006·British Journal of Cancer·R T KurmashevaP J Houghton
Jun 19, 2018·Journal of Clinical Gastroenterology·Barbara WlodarczykEwa Malecka-Panas
Aug 28, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J AlbanellF Rojo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.